NOOR MH, MUMTAZ AH, RAFIQ MF, ALI H, RAHMAN A, HAIDER MA. Open-Label Randomized Trial of High-Dose Rifampicin to Shorten Treatment for Drug-Sensitive Pulmonary TB (Hi-Dori-3). Annals Pak Med [Internet]. 2025 Oct. 30 [cited 2026 Jan. 15];1(7, October):7-11. Available from: https://annalspakmed.com/index.php/ojs/article/view/39